Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FAKNC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,213
Award facts
- Contract value 100% obligated
- $35,213.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $35,213.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 300 milligram/2 milliliter Dupixent (dupilumab) pens on January 20, 2026, with completion expected by January 21, 2026. This delivery order represents a child contract under AmerisourceBergen's parent company, Cencora, Inc., which maintains a significant $999,999,999 indefinite delivery contract with DLA Troop Support Medical through December 2026. The award was made on a fully competitive basis with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters.
Dupixent is a biologic medication commonly prescribed for eczema, asthma, and other allergic inflammatory conditions, indicating this procurement supports military healthcare system pharmaceutical needs. As a critical pharmaceutical distributor serving federal medical supply chains, AmerisourceBergen fulfills diverse procurement requirements across multiple therapeutic domains through its DLA prime vendor agreement, which enables the company to supply military treatment facilities, veterans' healthcare programs, and other federal medical institutions globally with a comprehensive range of brand-name and generic medications, vaccines, and specialized medical supplies.
Quick answers
Who was awarded contract SPE2DR26FAKNC?
SPE2DR26FAKNC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FAKNC worth?
The government has obligated $35,213 on SPE2DR26FAKNC.
Is contract SPE2DR26FAKNC an order under another contract?
Yes. SPE2DR26FAKNC is a delivery order under SPE2DR25D1201, an indefinite delivery contract.
Was contract SPE2DR26FAKNC competed?
The extent of competition for SPE2DR26FAKNC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award